2024-11-25 22:28:47
CStone presents ARROW study data for GAVRETO® (pralsetinib) in Chinese patients with RET-mutant medullary thyroid cancer (MTC) for the first time in a late breaking oral abstract session at the 90th Annual Meeting of the American Thyroid Association 2021
Corporate/ 2023-07-23
CStone presents ARROW study data for GAV...

Primary efficacy results showed GAVRETO had robust and durable anti-tumor activity in the Chinese patients with advanced or metastatic RET-m...

Kintor Pharma Announces First Patient Dosing in Phase III Clinical Trial of Proxalutamide for the Treatment of Hospitalized COVID-19 Patients in US
Corporate/ 2023-07-23
Kintor Pharma Announces First Patient Do...

SUZHOU,China,Oct. 4,2021-- Kintor Pharmaceutical Limited ("Kintor Pharma",HKEX: 9939),a clinical-stage biotechnology company devel...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release